Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Oxalobacter formigenes strain HC-1

EU orphan designation number: EU/3/14/1346   
Active ingredient: Oxalobacter formigenes strain HC-1
Indication: Treatment of short bowel syndrome
Sponsor: OxThera AB
Sturegatan 56, SE-114 36, Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/080/14 (2014)7645 of 15/10/2014